JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith, G. M.
Right arrow Articles by Beecher, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith, G. M.
Right arrow Articles by Beecher, H. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MORPHINE
Medline Plus Health Information
*Pain
Journal of Pharmacology And Experimental Therapeutics, Vol. 154, Issue 2, 324-332, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


AN EXPERIMENTAL PAIN METHOD SENSITIVE TO MORPHINE IN MAN: THE SUBMAXIMTUM EFFORT TOURNIQUET TECHNIQUE

Gene M. Smith 1, Lawrence D. Egbert 1, Robert A. Markowitz 1, Frederick Mosteller 1, and Henry K. Beecher 1

1 The Anaesthesia Laboratory, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts

There is great practical need for a dependable method of assessing effects of analgesics on experimental pain in man. Past use of threshold pain has not provided such a method. A technique, called here the submaximum effort tourniquet technique, was developed to produce experimental pain in man which simulates the duration and severity of pathologic pain more closely than earlier experimental methods. Pain was produced by having the subject squeeze a hand exerciser 20 times after a tourniquet had been inflated around his upper arm. Under appropriately controlled drug and placebo conditions, 45 male subjects (experiments I, II, III combined) were studied to determine the amount of time required for pain to build up to levels designated as slight, moderately distressing, very distressing and unbearable. Intravenous morphine, 10 mg/70 kg b.wt., was found to allay significantly the development of moderately distressing, very distressing and unbearable pain. There were indications that the 10-mg dosage of morphine might also be capable of allaying development of slight pain and that the 5-mg dosage might be capable of allaying development of unbearable pain, but these effects were not conclusive. Although the effect of 10 mg of morphine was more dependable (i.e., more statistically significant) at the higher pain levels than at the lower levels, the magnitude of the morphine effect was approximately a fixed multiple of the placebo score. Indeed, the largest morphine effect (expressed as percent of the placebo effect) was on the lowest pain level. When averaged for the four pain levels, the 10-mg dosage of morphine prolonged pain tolerance about 70%. It was concluded that appropriate use of the submaximum tourniquet technique produces a type of experimental pain which is responsive to the analgesic effects of 10 mg of intravenous morphine.

Submitted on December 15, 1965
Accepted on May 12, 1966




This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. Rantanen, H. Ypparila-Wolters, M. van Gils, A. Yli-Hankala, M. Huiku, M. Kymalainen, and I. Korhonen
Tetanic stimulus of ulnar nerve as a predictor of heart rate response to skin incision in propofol remifentanil anaesthesia
Br. J. Anaesth., October 1, 2007; 99(4): 509 - 513.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
O. Johansen, J. Brox, and M. A. Flaten
Placebo and Nocebo Responses, Cortisol, and Circulating Beta-Endorphin
Psychosom Med, September 1, 2003; 65(5): 786 - 790.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. I. M. Price, R. H. Curless, and H. Rodgers
Can Stroke Patients Use Visual Analogue Scales?
Stroke, July 1, 1999; 30(7): 1357 - 1361.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Amanzio and F. Benedetti
Neuropharmacological Dissection of Placebo Analgesia: Expectation-Activated Opioid Systems versus Conditioning-Activated Specific Subsystems
J. Neurosci., January 1, 1999; 19(1): 484 - 494.
[Abstract] [Full Text] [PDF]


Home page
Clin RehabilHome page
C. J Main and G. Waddell
The assessment of pain
Clinical Rehabilitation, November 1, 1989; 3(4): 267 - 274.
[PDF]


Home page
ScienceHome page
G. Timmermans and R. A. Sternbach
Factors of Human Chronic Pain: An Analysis of Personality and Pain Reaction Variables
Science, May 17, 1974; 184(4138): 806 - 808.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.